High prevalence of PER-1 extended-spectrum β-lactamase-producing Acinetobacter spp. in Korea

被引：75

作者：

Yong, DG

Shin, JH

Kim, SY

Lim, YS

Yum, JH

Lee, K

Chong, YS

Bauernfeind, A

机构：

[1] Yonsei Univ, Coll Med, Dept Lab Med, Seoul 120752, South Korea

[2] Yonsei Univ, Coll Med, Res Inst Bacterial Resistance, Seoul 120752, South Korea

[3] Yonsei Univ, Coll Med, Project Med Sci BK21, Seoul 120752, South Korea

[4] Chonnam Natl Univ, Sch Med, Dept Lab Med, Kwangju 501190, South Korea

[5] MICOER Inst, Munich, Germany

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2003年 / 47卷 / 05期

关键词：

D O I：

10.1128/AAC.47.5.1749-1751.2003

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

PER-1, an extended-spectrum beta-lactamase, has been reported only in Europe. We detected PER-1 in 53 of 97 acinetobacters in Korea, mainly in the sputum of intensive care unit patients. Pulsed-field gel electrophoresis analysis suggested that clonal spread had occurred. Only PCR reliably detected PER-1 producers. PER-1 producers may also exist in other Asian countries.

引用

收藏

页码：1749 / 1751

页数：3

相关论文

共 13 条

[1]

[Anonymous], 1999, M100S9 NAT COMM CLIN

[2]

[Anonymous], [No title captured]

[3] Characterization of beta-lactamase gene bla(PER-2,) which encodes an extended-spectrum class A beta-lactamase [J].

Bauernfeind, A ;

Stemplinger, I ;

Jungwirth, R ;

Mangold, P ;

Amann, S ;

Akalin, E ;

Ang, O ;

Bal, C ;

Casellas, JM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :616-620

[4] IN-VITRO ACTIVITIES OF CEFEPIME AGAINST ENTEROBACTER-CLOACAE, SERRATIA-MARCESCENS, PSEUDOMONAS-AERUGINOSA AND OTHER AEROBIC GRAM-NEGATIVE BACILLI [J].

CHONG, YS ;

LEE, KW ;

KWON, OH .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 :21-29

[5] blaVIM-2 Cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital [J].

Lee, K ;

Lim, JB ;

Yum, JH ;

Yong, DG ;

Chong, YS ;

Kim, JM ;

Livermore, DM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) :1053-1058

[6] Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase [J].

Luzzaro, F ;

Mantengoli, E ;

Perilli, M ;

Lombardi, G ;

Orlandi, V ;

Orsatti, A ;

Amicosante, G ;

Rossolini, GM ;

Toniolo, A .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (05) :1865-1870

[7] CHARACTERIZATION OF A NOVEL EXTENDED-SPECTRUM BETA-LACTAMASE FROM PSEUDOMONAS-AERUGINOSA [J].

NORDMANN, P ;

RONCO, E ;

NAAS, T ;

DUPORT, C ;

MICHELBRIAND, Y ;

LABIA, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :962-969

[8] SEQUENCE-ANALYSIS OF PER-1 EXTENDED-SPECTRUM BETA-LACTAMASE FROM PSEUDOMONAS-AERUGINOSA AND COMPARISON WITH CLASS-A BETA-LACTAMASES [J].

NORDMANN, P ;

NAAS, T .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (01) :104-114

[9] Extended-spectrum β-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France [J].

Poirel, L ;

Karim, A ;

Mercat, A ;

Le Thomas, I ;

Vahaboglu, H ;

Richard, C ;

Nordmann, P .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) :157-158

[10]

Schreckenberger PC, 1999, MANUAL CLIN MICROBIO, P539